Related Experiment Videos

A somatic mutation of the p21(Waf1/Cip1) gene in a human adrenocortical adenoma

S Iida1, H Fujii, K Moriwaki

  • 1Minami-Wakayama National Hospital, Japan.

Anticancer Research
|January 1, 1997
PubMed

Insights

A specific mutation in the p21 protein, an inhibitor of cell growth, was identified in an adrenal tumor. This alteration may contribute to the development of adrenocortical adenomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p21 protein (Waf1/Cip1) is crucial for inhibiting cellular growth and DNA replication, typically induced by the p53 tumor suppressor.
  • Inactivating mutations or deletions in p21 can lead to uncontrolled cellular proliferation.

Purpose of the Study:

  • To investigate the role of p21 alterations in the development of aldosterone-secreting adrenocortical adenomas.

Main Methods:

  • Genetic analysis of tumor tissue and patient fibroblasts.
  • Identification and characterization of mutations in the p21 cDNA sequence.

Main Results:

  • A heterozygous deletion of a 111-base-pair fragment in the p21 cDNA was found in an aldosterone-secreting adrenocortical adenoma.
  • This deletion resulted in a truncated p21 protein lacking 37 amino acids.
  • The mutation was identified as somatic, absent in the patient's normal fibroblast DNA.

Conclusions:

  • Alterations in the p21 protein may play a role in the pathogenesis of adrenocortical adenomas.
  • The identified p21 mutation could contribute to the benign, slow-growing nature of this tumor type.

Related Concept Videos